tirzepatide in mounjaro (tirzepatide) for the Treatment of Type 2 Diabetes, USA Mounjaro® (tirzepatide) injection and Zepbound®

They are research/compounded peptides and are not FDA-approved for these uses

Cardiovascular benefits have been demonstrated in clinical trials for specific GLP-1 receptor agonists, with liraglutide, semaglutide, and dulaglutide showing reductions in major adverse cardiovascular events in patients with established cardiovascular disease or high cardiovascular risk

Jianna coordinates scheduling, answers questions, and makes sure everything runs smoothly from your first call through your entire program

More strikingly, 45.3% of patients achieved weight reduction of 30% or more a threshold the company itself compared to bariatric surgery